| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |